 <h1>Methenamine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to methenamine: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, methenamine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking methenamine:</p><p>
<i>Less common</i>
</p><ul>
<li>Skin rash</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blood in urine</li>
<li>lower back pain</li>
<li>pain or burning while urinating</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of methenamine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Nausea and vomiting</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to methenamine: compounding powder, oral suspension, oral tablet</i></p><h3>General</h3><p>This drug was generally well tolerated.  Minor side effects have been reported in less than 3.5% of patients and were reversible when the drug was stopped.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus</p>
<p><b>Frequency not reported</b>: Generalized skin rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Gastric irritation</p>
<p><b>Frequency not reported</b>: Nausea, vomiting, upset stomach, stomatitis, gastrointestinal disturbances, diarrhea, abdominal cramping<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>High doses have been associated with albuminuria, gross hematuria, bladder irritation, and painful/frequent micturition.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Bladder irritation</p>
<p><b>Frequency not reported</b>: Dysuria, hematuria, urinary frequency, albuminuria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Elevated AST, elevated ALT<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Anorexia</p><h3>Ocular</h3><p><b>Frequency not reported</b>: Anterior uveitis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Hiprex (methenamine)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Gleckman R, Alvarez S, Joubert D, Matthews S "Drug therapy reviews: methenamine mandelate and methenamine hippurate." Am J Hosp Pharm 36 (1979): 1509-12</p><p id="ref_5">5. "Product Information. Mandelamine (methenamine)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_6">6. Australian Drug Evaluation Committee "Adverse effects of drugs commonly used in the treatment of urinary tract infection." Med J Aust 1 (1972): 435-8</p><p id="ref_7">7. Brumfitt W, Hamilton-Miller J, Gargan R, Cooper J, Smith GW "Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine." J Urol 130 (1983): 1110-4</p><p id="ref_8">8. Brumfitt W, Cooper J, Hamilton-Miller J "Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate." J Urol 126 (1981): 71-4</p><p id="ref_9">9. Kolker RJ "Medication-induced bilateral anterior uveitis." Arch Ophthalmol 109 (1991): 1343</p></div>
<div class="more-resources" id="moreResources">
<h2>More about methenamine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>67 Reviews</li>
<li>Drug class: urinary anti-infectives</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Methenamine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Hiprex, Urex, Mandelamine</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Prevention of Bladder infection</li>
<li>Urinary Tract Infection</li>
<li>Bladder Infection</li>
<li>Kidney Infections</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to methenamine: compounding powder, oral suspension, oral tablet</i></p><h3>General</h3><p>This drug was generally well tolerated.  Minor side effects have been reported in less than 3.5% of patients and were reversible when the drug was stopped.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus</p><p><b>Frequency not reported</b>: Generalized skin rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Gastric irritation</p><p><b>Frequency not reported</b>: Nausea, vomiting, upset stomach, stomatitis, gastrointestinal disturbances, diarrhea, abdominal cramping<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>High doses have been associated with albuminuria, gross hematuria, bladder irritation, and painful/frequent micturition.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Bladder irritation</p><p><b>Frequency not reported</b>: Dysuria, hematuria, urinary frequency, albuminuria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Elevated AST, elevated ALT<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Anorexia</p><h3>Ocular</h3><p><b>Frequency not reported</b>: Anterior uveitis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Hiprex (methenamine)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Gleckman R, Alvarez S, Joubert D, Matthews S "Drug therapy reviews: methenamine mandelate and methenamine hippurate." Am J Hosp Pharm 36 (1979): 1509-12</p><p id="ref_5">5. "Product Information. Mandelamine (methenamine)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_6">6. Australian Drug Evaluation Committee "Adverse effects of drugs commonly used in the treatment of urinary tract infection." Med J Aust 1 (1972): 435-8</p><p id="ref_7">7. Brumfitt W, Hamilton-Miller J, Gargan R, Cooper J, Smith GW "Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine." J Urol 130 (1983): 1110-4</p><p id="ref_8">8. Brumfitt W, Cooper J, Hamilton-Miller J "Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate." J Urol 126 (1981): 71-4</p><p id="ref_9">9. Kolker RJ "Medication-induced bilateral anterior uveitis." Arch Ophthalmol 109 (1991): 1343</p><h2>More about methenamine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>67 Reviews</li>
<li>Drug class: urinary anti-infectives</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Methenamine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Prevention of Bladder infection</li>
<li>Urinary Tract Infection</li>
<li>Bladder Infection</li>
<li>Kidney Infections</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>